MESOTHELIOMA | 2025-12-13

Immunotherapy for Mesothelioma in California: Opdivo and Yervoy Treatment Options

FDA-Approved Immunotherapy and Clinical Trials for Mesothelioma Patients

By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published

Immunotherapy has revolutionized mesothelioma treatment, offering new hope for patients with this aggressive asbestos-caused cancer. In 2020, the FDA approved the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) for treating mesothelioma.

Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.

Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301